TALENs targeting HBV: Designer endonuclease therapies for viral infections

Molecular Therapy

Volumn 21, Issue 10, 2013, Pages 1819-1821

  Weber, Nicholas D ^a,b   Stone, Daniel ^a   Jerome, Keith R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COVALENTLY CLOSED CIRCULAR DNA; DNA; HEPATITIS B VACCINE; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; VIRUS DNA; ZINC FINGER NUCLEASE;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL (TOPIC); DNA REPAIR; DNA SEQUENCE; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; GENE DISRUPTION; GENE SILENCING; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRODYNAMICS BASED TRANSFECTION; MOLECULAR RECOGNITION; NONHUMAN; NOTE; PARTICLE SIZE; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INHIBITION;

HEPATITIS B VIRUS;

ANIMALS; DEOXYRIBONUCLEASES; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; VIRUS REPLICATION;

EID: 84885016939     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.208     Document Type: Note

References (19)

1. Schiffer, JT, Aubert, M, Weber, ND, Mintzer, E, Stone, D and Jerome, KR (2012). Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol 86: 8920-8936.
2. Bloom, K, Ely, A, Mussolino, C, Cathomen, T and Arbuthnot, P (2013). Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 21: 1889-1897.
3. Holt, N, Wang, J, Kim, K, Friedman, G, Wang, X, Taupin, V et al. (2010). Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28: 839-847.
4. Perez, EE, Wang, J, Miller, JC, Jouvenot, Y, Kim, KA, Liu, O et al. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816.
5. Stone, D, Kiem, H and Jerome, KR (2013). Targeted gene disruption to cure HIV. Curr Opin HIV AIDS 8: 217-223.
6. Cradick, TJ, Keck, K, Bradshaw, S, Jamieson, AC and McCaffrey, AP (2010). Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther 18: 947-954.
7. Zimmerman, KA, Fischer, KP, Joyce, MA and Tyrell, DL (2008). Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J Virol 82: 8013-8021.
8. Qu, X, Wang, P, Ding, D, Li, L, Wang, H, Ma, L et al. (2013). Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res 41: 7771-7782.
9. Tanaka, A, Takeda, S, Kariya, R, Matsuda, K, Urano, E, Okada, E et al. (2013). A novel therapeutic molecule against HTLV-1 infection targeting provirus. Leukemia 27: 1621-1627.
10. Mino, T, Mori, T, Aoyama, Y and Sera, T (2013). Geneand protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus. PLoS One 8: e56633.
11. Grosse, S, Huot, N, Mahiet, C, Arnould, S, Barradeau, S, Clerre, DL et al. (2011). Meganuclease-mediated inhibition of HSV1 infection in cultured cells. Mol Ther 19: 694-702.
12. Doyon, Y, Choi, VM, Xia, DF, Vo, TD, Gregory, PD and Holmes, MC (2010). Transient cold shock enhances zinc-finger nuclease-mediated gene disruption. Nat Methods 7: 459-460.
13. Yang, PL, Althage, A, Chung, J and Chisari, FV (2002). Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA 99: 13825-13830.
14. Suda, T, Kamimura, K, Kubota, T, Tamura, Y, Igarashi, M, Kawai, H et al. (2009). Progress toward liver-based gene therapy. Hepatol Res 39: 325-340.
15. Schiffer, JT, Swan, DA, Stone, D and Jerome, KR (2013). Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach. PLoS Comput Biol 9: e1003131.
16. Chen, CC, Sun, CP, Ma, HI, Fang, CC, Wu, PY, Xiao, X et al. (2009). Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol Ther 17: 352-359.
17. Nathwani, AC, Tuddenham, EG, Rangarajan, S, Rosales, C, McIntosh, J, Linch, DC et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365: 2357-2365.
18. Beurdeley, M, Bietz, F, Li, J, Thomas, S, Stoddard, T, Juillerat, A et al. (2013). Compact designer TALENs for efficient genome engineering. Nat Commun 4: 1762.
19. Boissel, S, Certo, M, Stoddard, B and Scharenberg, A (2013). Megatals: a novel designer rare-cleaving nuclease scaffold for highly active and specific genome engineering. Presented at the BioBricks Foundation Sixth International Meeting on Synthetic Biology (SB6.0), London, 9-11 July 2013.